2012 © Institute for Molecular Medicine Finland FIMM
PI Sirpa Jalkanen
Principal Investigator:
Academy Professor Sirpa Jalkanen, MD, PhD
Primary Affiliation:
Center of Excellence , University of Turku
Title of the FIMM-Specific Research Project:
Role of trafficking molecules in cancer spread and harmful inflammations
Abstract:
Jalkanen's interests are in mechanisms mediating leukocyte trafficking to sites of inflammation and metastatic spread of cancer cells in the body. The final goal of the research is to identify target molecules to be used in drug development against harmful inflammations and cancer spread. The FIMM related work tackles two specific questions (depicted also in Figure 1):
- Which are the trafficking molecules behind cancer spread?
- Which are the molecules mediating cell migration via lymphatics?

The above-mentioned projects will be performed in close collaboration with FIMM and its associates. Besides the expertise in multitude of modern molecular and cellular biology methods, imaging and animal models within the Jalkanen group, the data banks, high through put screening methods and carefully controlled clinical materials within FIMM and its associates are the corner stones for the success of these projects.
Contact information:
Sirpa Jalkanen, MD, PhD
Professor of Immunology
Director of the Center of Excellence in Host Defence Research
MediCity Research Laboratory
University of Turku
Tykistökatu 6A
FI-20520 Turku, Finland
Tel: +358-2-333-7007
Fax: +358-2-333-7000
e-mail: sirpa.jalkanen(at)utu.fi
home page: http://research.utu.fi/receptor/projects/sjalkane/sjalkane.html